NCT02905890View on ClinicalTrials.gov

The Effect of Norethisterone Enanthate on Recurrent Bacterial Vaginosis

PHASE4CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

October 2, 2017

Primary Completion Date

December 20, 2019

Study Completion Date

December 20, 2019

Conditions
Bacterial VaginosisHIV
Interventions
DRUG

Norethisterone enantate

Noristerat® 200mg, solution for intramuscular injection given every 8 weeks

DEVICE

Condoms

Latex male condoms

Trial Locations (1)

Unknown

MRC/UVRI Mengo Clinic and Research Station, Kampala

All Listed Sponsors
collaborator

Imperial College London

OTHER

collaborator

University of Liverpool

OTHER

collaborator

MRC/UVRI and LSHTM Uganda Research Unit

OTHER

lead

London School of Hygiene and Tropical Medicine

OTHER

NCT02905890 - The Effect of Norethisterone Enanthate on Recurrent Bacterial Vaginosis | Biotech Hunter | Biotech Hunter